Company intelligence / Profile preview

LI Lending

Bellevue, Washington, United States

Ownership: Private
Development stage: Other

Overview

LI Lending is a U.S.-based investment and lending company, not a life sciences, biotech, pharma, or healthcare operating company. Publicly available business descriptions characterize it as an investment company focused on investing directly or indirectly in securities, loans, and other investments. The firm has appeared in public disclosures as a senior secured lender to 4Front Ventures, where it participated in a debt-to-equity conversion transaction in 2024. Based on the available evidence, LI Lending does not appear to develop therapeutics, diagnostics, medical devices, or healthcare services.

Industry: Investors

Partnerships

4Front Ventures (senior secured lending relationship)

Beyond the preview

Go deeper on LI Lending.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LI Lending.

Explore the full profile